07/31/2003
Federal Register Notice: FDA has determined the regulatory review period for Sankyo’s Benicar (olmesartan medocomil) is 2,52...07/31/2003
Federal Register Notice: FDA’s Anesthetic and Life Support Drugs Advisory Committee will meet 9/9-10 from 8 a.m. to 5 p.m. a...07/31/2003
Federal Register Final rule: FDA is amending the animal drug regulations to reflect a change of sponsor for three approved new ani...07/30/2003
Federal Register Proposed rule: FDA is proposing to revise the labeling and storage requirements for certain human blood and blood...07/28/2003
Federal Register Notice: FDA is classifying the breast lesion documentation system into Class II (special controls) and is making ...07/28/2003
Federal Register Notice: FDA is making available a draft guidance for reviewers and industry entitled Good Review Management Princ...07/28/2003
Federal Register Notice: FDA’s collection of information entitled “Records and Reports Concerning Experience With Appr...07/28/2003
Federal Register Notice: FDA’s collection of information entitled “FDA Safety Alert/Public Health Advisory Readership ...